Baseline fdg pet/ct-derived tumor burden and host metabolic activity predict complete metabolic response to neoadjuvant chemotherapy in ınvasive ductal breast cancer.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.